Merck developed the drug Vioxx to treat arthritis pain. It was approved by the FDA in 1999 but later studies showed it increased risks of heart attacks and strokes. Merck faced thousands of lawsuits and eventually paid $4.85 billion to settle claims after voluntarily withdrawing Vioxx from the market in 2004. The document discusses the history of Merck and development of Vioxx, clinical trials that showed safety issues, lawsuits against Merck, and recommendations for how the FDA could strengthen drug safety processes going forward to prevent similar situations.